Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
about
Proteomics and metabolomics in renal transplantation-quo vadis?Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology.Global proteomics and metabolomics in cancer biomarker discovery.Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetesUrinary proteomics for early diagnosis in diabetic nephropathy.Ultrasensitive sample quantitation via selected reaction monitoring using CITP/CZE-ESI-triple quadrupole MS.Screening for urinary biomarkers of steroid-resistant nephrotic syndrome in children.Biomarker discovery in mass spectrometry-based urinary proteomics.Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.Significance of urinary proteome pattern in renal allograft recipients.Clinical application of urinary proteomics/peptidomics.Proteomics in hypertension and other cardiovascular diseases.Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications.Review of the CE-MS platform as a powerful alternative to conventional couplings in bio-omics and target-based applications.Proteomic urinary biomarker approach in renal disease: from discovery to implementation.Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases.Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics.Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine.Body fluid peptide and protein signatures in diabetic kidney diseases.Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.Urinary proteomics for the study of genetic kidney diseases.The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease.Urinary biomarkers for renal tract malformations.Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease.Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.Renal histological features of school-age children with asymptomatic haematuria and/or proteinuria: a multicenter study.Urinary peptidomics in kidney disease and drug research.Applying proteomics to diagnosis of diabetic kidney disease.Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion.A urinary proteome-based classifier for the early detection of decline in glomerular filtration.Current Application of Capillary Electrophoresis in Nanomaterial Characterisation and Its Potential to Characterise the Protein and Small Molecule Corona.Untargeted Screening of Urinary Peptides Using Offline Nano-Liquid Chromatography: MALDI-TOF/TOF Mass Spectrometry.Prediction of Proteases Involved in Peptide Generation.Fetal Urinary Peptides to Predict Postnatal Outcome of Renal Disease in Fetuses with Posterior Urethral Valves (PUV)
P2860
Q27024418-CC02991C-2A94-4443-8CB8-9F4B652DE11CQ34039254-0B5A5C42-AAF0-4AA6-9D43-7095658A0C07Q34079038-91B94344-A88E-4AAA-84FE-5079D919396EQ35878999-FD3D27EA-48BC-4754-99F8-19C352CC34A4Q36410737-611F36D3-AF03-43C3-97B4-DAAF570D1AFEQ36540986-1C426E69-1394-4645-A3DA-E83C67532846Q36603656-6E283AFA-D3DE-4BC4-B32C-C545B8B19550Q36956324-C5570313-F00C-4D75-ABB3-B9ACDB37534AQ37552845-7199C72C-0778-4BCC-B698-6BA1385CBD0AQ37686749-683C26FC-9278-4B80-86DF-EB36BA110213Q37945790-0943A2B9-6FAE-4A43-ADAC-21141DF65E46Q38020003-E34485EC-EA5C-432F-895B-79B269B25664Q38091336-C780E461-62CF-443E-B853-091CC424FBCEQ38184491-2F8A9AC4-D0AA-4288-AB2F-7A2054B0617CQ38196316-FE8131BE-1C0F-4462-9F00-538AFB95E3E6Q38222628-C73B5E8A-8BE0-42C6-BCDE-2B5525C0197CQ38340351-0A27AA25-5EC3-4F86-8EDB-FB8E14C67E9FQ38553911-1AABF324-3B10-45CD-AF43-5555280FA520Q38553924-F97AAACE-C9B8-4536-B1A0-119C33AF9150Q38553932-E6900F24-796C-45F2-98C1-F2BF1118B5ABQ38677349-6A9DCB7B-6C63-4E32-87DD-75E4CB77A27DQ38786133-AB214368-B67B-4FAC-95EE-182CD924B9DDQ38993548-2B72742F-5A70-49F2-A396-14D290CA635EQ39427234-EB56B758-9FF7-4809-B6B8-B78192FD0126Q41190815-EC0CD4E2-F5C4-4718-860A-B3A009AE1FFDQ44006761-218AB230-2A90-4385-88EA-213A2B2A86F0Q47781932-4B45B4C5-19D6-42F7-8664-47C97FE94E02Q48092320-F2EC4CC0-BE20-4F9A-A6A1-DC9BFF8AFBA8Q48610499-87D0313C-F7F3-43B9-A7B2-653B23AB1400Q49037974-CCF28E78-F810-4A22-B024-553884D2417BQ50034205-BB676D40-36EA-4879-8015-8A3ABC7EAE73Q50078073-FEB9C90E-1439-4814-8B41-DEB2942D377DQ51094837-59F55FB1-C221-4D01-ACF8-B8EE77774DF5Q57711889-E31AEA3B-2808-40F5-ABE5-0321A5AC0545
P2860
Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Urinary proteomics based on ca ...... ers, and clinical application.
@en
Urinary proteomics based on ca ...... ers, and clinical application.
@nl
type
label
Urinary proteomics based on ca ...... ers, and clinical application.
@en
Urinary proteomics based on ca ...... ers, and clinical application.
@nl
prefLabel
Urinary proteomics based on ca ...... ers, and clinical application.
@en
Urinary proteomics based on ca ...... ers, and clinical application.
@nl
P50
P1476
Urinary proteomics based on ca ...... ers, and clinical application.
@en
P2093
Christian Delles
P304
P356
10.1053/J.ACKD.2010.09.004
P577
2010-11-01T00:00:00Z